D3Sciences

D3Sciences is a medical technology company that developed the D3S platform, an integrated system for precision oncology, specifically targeting breast cancer. The platform combines diagnostic imaging, radiation dosimetry, and therapeutic delivery into a single workflow to enhance treatment accuracy and patient outcomes. By providing real-time data and targeted intervention, the D3S system aims to minimize damage to healthy tissue and streamline the clinical pathway from detection to treatment. The company's technology originated from research at Dartmouth College's Thayer School of Engineering and was designed to address the limitations of conventional radiation therapy. Although the company's current operational status is inactive, its innovations represent a significant step in the integration of diagnostics and therapeutics in oncology.